Oxaliplatin: all 947 studies that test it

Page 10 of 10. Open to participants first (145), then studies with results posted, then the rest; newest registration first within each.

• Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With IrinotecanCompletedNCT00016978Phase 2
• Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal CancerCompletedNCT00016198Phase 2
• Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal CancerCompletedNCT00012389Phase 3
• Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal CancerCompletedNCT00008294Phase 1
• Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00008281Phase 3
• Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal CancerCompletedNCT00008060Phase 3
• Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerStatus unknownNCT00006479Phase 3
• Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00006473Phase 2
• Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00006468Phase 3
• Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00006465Phase 1
• Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT00006391Phase 1
• Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous ChemotherapyTerminatedNCT00006121Phase 2
• Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerStatus unknownNCT00006117Phase 2
• Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00006115Phase 2
• Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the RectumCompletedNCT00006094Phase 1/2
• Oxaliplatin to Treat Advanced Cancers With Liver DysfunctionCompletedNCT00006062Phase 1
• Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the LiverCompletedNCT00006050Phase 2
• Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal CancerTerminatedNCT00006015Phase 2
• Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumCompletedNCT00005860Phase 1
• Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma MultiformeTerminatedNCT00005856Phase 1/2
• Oxaliplatin in Treating Children With Advanced Solid TumorsCompletedNCT00005844Phase 1
• Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid TumorCompletedNCT00005839Phase 1
• Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical CancerCompletedNCT00005837Phase 2
• Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based ChemotherapyCompletedNCT00005836Phase 2
• Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver DysfunctionCompletedNCT00005077Phase 1
• Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00005068Phase 1
• Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal CancerCompletedNCT00005050Phase 1/2
• Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerCompletedNCT00005036Phase 3
• Oxaliplatin in Treating Patients With Advanced Head and Neck CancerCompletedNCT00005035Phase 2
• Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon CancerCompletedNCT00004931Phase 3
• Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach CancerCompletedNCT00004257Phase 1
• Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid TumorCompletedNCT00004243Phase 1
• Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00004242Phase 1
• Oxaliplatin and Gemcitabine in Treating Patients With Advanced CancerCompletedNCT00004220Phase 1
• Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian CancerStatus unknownNCT00004206Phase 2
• Oxaliplatin in Treating Patients With Metastatic Bladder CancerCompletedNCT00004203Phase 2
• Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00004190Phase 2
• Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal CancerCompletedNCT00004187Phase 1/2
• Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable CancerStatus unknownNCT00004173Phase 1
• Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or StomachCompletedNCT00004127Phase 2
• Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung CancerCompletedNCT00004126Phase 2
• Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerCompletedNCT00003834Phase 2
• Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal CancerCompletedNCT00003799Phase 1
• Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerCompletedNCT00003594Phase 3
• Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal CancerCompletedNCT00003427Phase 1
• Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal CancerCompletedNCT00003287Phase 3
• Oxaliplatin in Cancer Patients With Impaired Kidney FunctionCompletedNCT00001835Phase 1

← Oxaliplatin overview